Emergent BioSolutions Inc (EBS)
9.40
+0.52
(+5.86%)
USD |
NYSE |
Nov 21, 16:00
9.50
+0.10
(+1.06%)
Pre-Market: 06:57
Emergent BioSolutions Market Cap: 509.33M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 21, 2024 | 509.33M |
| November 20, 2024 | 481.16M |
| November 19, 2024 | 448.10M |
| November 18, 2024 | 465.98M |
| November 15, 2024 | 418.30M |
| November 14, 2024 | 502.29M |
| November 13, 2024 | 540.22M |
| November 12, 2024 | 590.07M |
| November 11, 2024 | 648.58M |
| November 08, 2024 | 637.75M |
| November 07, 2024 | 596.03M |
| November 06, 2024 | 498.49M |
| November 05, 2024 | 485.49M |
| November 04, 2024 | 475.20M |
| November 01, 2024 | 494.16M |
| October 31, 2024 | 490.91M |
| October 30, 2024 | 520.17M |
| October 29, 2024 | 504.37M |
| October 28, 2024 | 522.75M |
| October 25, 2024 | 482.75M |
| October 24, 2024 | 489.78M |
| October 23, 2024 | 473.02M |
| October 22, 2024 | 498.97M |
| October 21, 2024 | 550.32M |
| October 18, 2024 | 505.46M |
| Date | Value |
|---|---|
| October 17, 2024 | 494.10M |
| October 16, 2024 | 495.18M |
| October 15, 2024 | 496.81M |
| October 14, 2024 | 486.53M |
| October 11, 2024 | 473.02M |
| October 10, 2024 | 456.80M |
| October 09, 2024 | 482.75M |
| October 08, 2024 | 498.43M |
| October 07, 2024 | 497.35M |
| October 04, 2024 | 505.46M |
| October 03, 2024 | 483.29M |
| October 02, 2024 | 496.81M |
| October 01, 2024 | 457.88M |
| September 30, 2024 | 451.40M |
| September 27, 2024 | 396.27M |
| September 26, 2024 | 385.16M |
| September 25, 2024 | 314.27M |
| September 24, 2024 | 323.26M |
| September 23, 2024 | 320.61M |
| September 20, 2024 | 346.54M |
| September 19, 2024 | 369.82M |
| September 18, 2024 | 365.06M |
| September 17, 2024 | 364.00M |
| September 16, 2024 | 383.57M |
| September 13, 2024 | 416.37M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
78.30M
Minimum
Feb 07 2024
7.142B
Maximum
Aug 13 2020
2.098B
Average
1.657B
Median
Market Cap Benchmarks
| Geovax Labs Inc | 25.48M |
| Tonix Pharmaceuticals Holding Corp | 38.16M |
| Abbott Laboratories | 203.38B |
| Insulet Corp | 18.38B |
| SIGA Technologies Inc | 447.71M |
Market Cap Related Metrics
| PS Ratio | 0.4564 |
| Price to Book Value | 1.002 |
| Price to Free Cash Flow | 3.616 |
| Price | 9.40 |
| Earnings Yield | -43.62% |